Intrexon | XON - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Agenus USD 82.99M 2.3M 2025-12
Alaunos Therapeutics USD 613K 230K 2025-12
Amgen USD 19.52B 1.37B 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Heron Therapeutics USD 8.99M 3.02M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Intrexon USD 4.85M 3.12M 2024-06
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
MannKind USD 9.03M 1.76M 2025-12
Merck USD 3.86B 541M 2026-03
Novartis USD 4.32B 134M 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Veracyte USD 4.59M 916K 2025-12
Xencor USD 10.83M 1.75M 2025-12